« Back
Home /
Partner: Angio Proteomie |Hölzel Diagnostika

Angio Proteomie

Angio-Proteomie

Angio-Proteomie is a cutting-edge biotechnology company specializing in innovative solutions for proteomic research with a focus on angiogenesis. Their mission is to advance the field of angiogenesis research and contribute to the development of novel therapeutics for various diseases.

Angiogenesis is the process of new blood vessel formation from existing blood vessels. It plays a crucial role in various physiological and pathological processes, including embryonic development, tissue repair, and diseases such as cancer, cardiovascular diseases, and inflammatory conditions. Understanding the molecular mechanisms underlying angiogenesis is essential for developing therapeutic interventions for these diseases.

Proteomic research is a powerful approach used to study the complex protein networks and signaling pathways involved in angiogenesis. Proteomics involves the comprehensive study of the entire set of proteins expressed in a particular tissue or cell at a given time, allowing researchers to gain insights into the dynamic changes in protein expression and modifications during angiogenesis.

Proteomic research in the field of angiogenesis involves the use of various techniques, such as mass spectrometry, protein microarrays, and quantitative proteomics, to analyze and characterize the proteome of angiogenic tissues or cells. These techniques enable researchers to identify and quantify the proteins involved in angiogenesis, elucidate their interactions, and uncover their functional roles in the complex process of blood vessel formation.

Proteomic research in angiogenesis has several applications. Firstly, it can help identify novel angiogenesis-related proteins and signaling pathways, providing new targets for therapeutic intervention. For example, identifying specific proteins that are upregulated or downregulated during angiogenesis can reveal potential biomarkers or therapeutic targets for diseases such as cancer, where angiogenesis plays a critical role in tumor growth and metastasis.

Secondly, proteomic research can provide insights into the mechanisms of action of angiogenesis-modulating drugs. By studying the changes in protein expression and modifications in response to drug treatment, researchers can understand how these drugs affect angiogenesis and develop more effective therapeutic strategies.

Furthermore, proteomic research can contribute to the development of personalized medicine approaches in angiogenesis-related diseases. By analyzing the proteome of individual patients, researchers can identify specific protein signatures associated with disease progression or treatment response, enabling personalized treatment plans tailored to each patient's unique proteomic profile.

As a leader in the field of angiogenesis research, Angio-Proteomie offers a wide range of products and services tailored to meet the needs of researchers worldwide.

One of Angio-Proteomie's core offerings is our extensive catalog of angiogenesis-related products. Angio-Proteomie provides a wide range of high-quality research reagents, including antibodies, recombinant proteins, and assay kits, specifically designed for studying angiogenesis. These products are meticulously tested and validated to ensure reliable and reproducible results, making them invaluable tools for researchers conducting angiogenesis-related studies.

In addition to their product offerings, Angio-Proteomie also provides a range of services to support researchers in their proteomic research endeavors. Their team of experts offers custom protein expression and purification services, as well as peptide synthesis and antibody development services. These services are tailored to meet the unique needs of each researcher, providing customized solutions for their specific proteomic research needs.

Angio-Proteomie is committed to providing exceptional customer service.